{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:45:02Z","timestamp":1793231102477,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010224.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000}}],"reference-count":227,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010224.pub3","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T09:23:35Z","timestamp":1693301015000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child"],"prefix":"10.1002","volume":"2023","author":[{"given":"Rebecca","family":"Bromley","sequence":"additional","affiliation":[{"name":"Division of Neuroscience; University of Manchester; Manchester UK"},{"name":"Royal Manchester Children's Hospital; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghme","family":"Adab","sequence":"additional","affiliation":[{"name":"Department of Neurology, A5 Corridor; Walsgrave Hospital, University Hospitals Coventry and Warwickshire NHS Trust; Coventry UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Bluett-Duncan","sequence":"additional","affiliation":[{"name":"Institute of Human Development; University of Manchester; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Clayton-Smith","sequence":"additional","affiliation":[{"name":"Institute of Human Development; University of Manchester; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Neurology; Aarhus University Hospital; Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Edwards","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Greenhalgh","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruaraidh A","family":"Hill","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group, Department of Health Data Science; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cerian F","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology; Institute of Translational Medicine, University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Khanom","sequence":"additional","affiliation":[{"name":"Institute of Human Development; University of Manchester; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan N","family":"McGinty","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences; John Radcliffe Hospital; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Tudur Smith","sequence":"additional","affiliation":[{"name":"Department of Health Data Science; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pulman","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology; Institute of Translational Medicine, University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics; Institute of Systems, Molecular and Integrative Biology, University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/seiz.1998.0239","article-title":"Outcome of pregnancies in epileptic women: a study in Saudi Arabia","volume":"8","author":"Al Bunyan","year":"1999","journal-title":"Seizure"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.17712\/nsj.2020.1.20190077","article-title":"Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes","volume":"25","author":"AlSheikh","year":"2020","journal-title":"Neurosciences"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.seizure.2018.02.009","article-title":"Outcomes of pregnancies in women taking antiepileptic drugs for non-epilepsy indications","volume":"56","author":"Jazayeri","year":"2018","journal-title":"Seizure"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.0013-9580.2004.451103.x","article-title":"Australian pregnancy registry of women taking antiepileptic drugs","volume":"45","author":"Vajda","year":"2004","journal-title":"Epilepsia"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1212\/WNL.0b013e3182a43e81","article-title":"Dose dependence of fetal malformations associated with valproate","volume":"81","author":"Vajda","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2005.00458.x","article-title":"Maternal valproate dosage and foetal malformations","volume":"112","author":"Vajda","year":"2005","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jocn.2011.08.003","article-title":"Teratogenicity of the newer antiepileptic drugs - the Australian experience","volume":"19","author":"Vajda","year":"2012","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.seizure.2018.12.006","article-title":"Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register","volume":"65","author":"Vajda","year":"2019","journal-title":"Seizure"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.seizure.2010.07.019","article-title":"Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register","volume":"19","author":"Vajda","year":"2010","journal-title":"Seizure"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1479-828X.2007.00781.x","article-title":"The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies","volume":"47","author":"Vajda","year":"2007","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"7","key":"10.1002\/14651858.CD010224.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jocn.2006.04.025","article-title":"Changing Australian prescribing patterns for antiepileptic drugs in pregnancy and their possible consequences","volume":"14","author":"Vajda","year":"2007","journal-title":"Journal of Clinical Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ane.12115","article-title":"Associations between particular types of fetal malformation and antiepileptic drug exposure in utero","volume":"128","author":"Vajda","year":"2013","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jocn.2015.07.011","article-title":"Is carbamazepine a human teratogen?","volume":"23","author":"Vajda","year":"2016","journal-title":"Journal of Clinical Neuroscience"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eplepsyres.2014.04.005","article-title":"Prediction of the hazard of foetal malformation in pregnant women with epilepsy","volume":"108","author":"Vajda","year":"2014","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ane.12672","article-title":"Antiepileptic drugs, foetal malformations and spontaneous abortions","volume":"135","author":"Vajda","year":"2017","journal-title":"Acta Neurologica Scandinavica"},{"issue":"Pt A","key":"10.1002\/14651858.CD010224.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"106481","DOI":"10.1016\/j.yebeh.2019.106481","article-title":"Preexisting illness, fetal malformation, and seizure control rates in pregnant women with epilepsy","volume":"103","author":"Vajda","year":"2020","journal-title":"Epilepsy & Behavior"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/epi.16505","article-title":"Pregnancy after valproate withdrawal - fetal malformations and seizure control","volume":"61","author":"Vajda","year":"2020","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ane.13005","article-title":"Valproate-associated foetal malformations - rates of occurrence, risks in attempted avoidance","volume":"139","author":"Vajda","year":"2019","journal-title":"Acta Neurologica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD010224.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2004.05.003","article-title":"Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy","volume":"11","author":"Vajda","year":"2004","journal-title":"Journal of Clinical Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0967-5868(03)00158-9","article-title":"The Australian Registry of Anti-Epileptic Drugs in Pregnancy: experience after 30 months","volume":"10","author":"Vajda","year":"2003","journal-title":"Journal of Clinical Neuroscience"},{"issue":"7","key":"10.1002\/14651858.CD010224.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/epi.13415","article-title":"Antiepileptic drug combinations not involving valproate and the risk of fetal malformations","volume":"57","author":"Vajda","year":"2016","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1528-1167.2012.03625.x","article-title":"Teratogenesis in repeated pregnancies in antiepileptic drug-treated women","volume":"54","author":"Vajda","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00314466","article-title":"Pregnancy and epilepsy","volume":"236","author":"Bag","year":"1989","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0024|cit24","first-page":"601","article-title":"Evaluation of antiepileptic drugs in pregnancy in a Jordanian army hospital","volume":"11","author":"Barqawi","year":"2005","journal-title":"Eastern Mediterranean Health Journal"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.reprotox.2013.04.002","article-title":"Pregnancy outcome in women exposed to antiepileptic drugs: teratogenic role of maternal epilepsy and its pharmacologic treatment","volume":"39","author":"Cassina","year":"2013","journal-title":"Reproductive Toxicology"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/adc.66.3.320","article-title":"Fetal phenytoin exposure, hypoplastic nails, and jitteriness","volume":"65","author":"D'Souza","year":"1991","journal-title":"Archives of Disease in Childhood"},{"issue":"1-2","key":"10.1002\/14651858.CD010224.pub3-BIB0027|cit27","first-page":"23","article-title":"Epilepsy in pregnancy","volume":"31","author":"\u0110elmi\u0161","year":"1991","journal-title":"Jugoslavenska Ginekologija i Perinatologija"},{"issue":"12","key":"10.1002\/14651858.CD010224.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1111\/epi.17085","article-title":"Prenatal exposure to valproate and risk of congenital malformations - could we have known earlier? A population-based cohort study","volume":"62","author":"Christensen","year":"2021","journal-title":"Epilepsia"},{"issue":"19","key":"10.1002\/14651858.CD010224.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2011.624","article-title":"Newer-generation antiepileptic drugs and the risk of major birth defects","volume":"305","author":"M\u00f8lgaard-Nielsen","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0030|cit30","first-page":"53","article-title":"Pregnancy and teratogenicity of antiepileptic drugs","volume":"108","author":"Ero\u011flu","year":"2008","journal-title":"Acta Neurologica Belgica"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00415-020-09764-w","article-title":"Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure","volume":"267","author":"Huber-Mollema","year":"2020","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurology"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1212\/WNL.0000000000008001","article-title":"Declining malformation rates with changed antiepileptic drug prescribing: an observational study","volume":"93","author":"Tomson","year":"2019","journal-title":"Neurology"},{"issue":"10","key":"10.1002\/14651858.CD010224.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","article-title":"Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study","volume":"85","author":"Tomson","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD010224.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1002\/14651858.CD010224.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0000000000001840","article-title":"Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP","volume":"85","author":"Tomson","year":"2015","journal-title":"Neurology"},{"issue":"7262","key":"10.1002\/14651858.CD010224.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bmj.321.7262.674","article-title":"Population based, prospective study of the care of women with epilepsy in pregnancy","volume":"321","author":"Fairgrieve","year":"2000","journal-title":"British Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/01.WNL.0000163771.96962.1F","article-title":"Antiepileptic drug use of women with epilepsy and congenital malformations in offspring","volume":"64","author":"Artama","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ije\/dyi234","article-title":"Congenital structural anomalies in offspring of women with epilepsy - a population-based cohort study in Finland","volume":"35","author":"Artama","year":"2006","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0040|cit40","first-page":"389","article-title":"The course of pregnancy and teratogenicity of antiepileptic agents in 66 patients with epilepsy","volume":"142","author":"Fr\u00f6scher","year":"1991","journal-title":"Schweizer Archiv fur Neurologie und Psychiatrie"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0041|cit41","first-page":"449","article-title":"Epilepsy and pregnancy: prospective study of 100 cases","volume":"64","author":"Garza-Morales","year":"1996","journal-title":"Ginecologi\u0301a y Obstetricia de Me\u0301xico"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"108251","DOI":"10.1016\/j.yebeh.2021.108251","article-title":"Risk factors of fetal deaths and major birth defects in newborns of women with epilepsy: an Egyptian prospective study","volume":"123","author":"Hosny","year":"2021","journal-title":"Epilepsy & Behavior"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.57.2.321","article-title":"Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies","volume":"57","author":"Diav-Citrin","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200822040-00004","article-title":"Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect","volume":"22","author":"Diav-Citrin","year":"2008","journal-title":"CNS Drugs"},{"issue":"15","key":"10.1002\/14651858.CD010224.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/bdr2.1058","article-title":"Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study","volume":"109","author":"Diav-Citrin","year":"2017","journal-title":"Birth Defects Research"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.75.6.517","article-title":"Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy","volume":"75","author":"Ornoy","year":"1996","journal-title":"Archives of Disease in Childhood"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.reprotox.2008.03.001","article-title":"The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies","volume":"25","author":"Ornoy","year":"2008","journal-title":"Reproductive Toxicology"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yebeh.2018.09.033","article-title":"Perinatal outcome and healthcare resource utilization in the first year of life after antiepileptic exposure during pregnancy","volume":"92","author":"Putignano","year":"2019","journal-title":"Epilepsy & Behavior"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nrl.2020.04.024","article-title":"Epilepsy and pregnancy. Factors associated with epileptic seizures during pregnancy","volume":"38","author":"Jim\u00e9nez","journal-title":"Neurologia (Engl Ed)"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/01.WNL.0000044157.28073.DC","article-title":"Major malformations in offspring of women with epilepsy","volume":"60","author":"Kaaja","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0051|cit51","first-page":"478","article-title":"Teratogenicity of antiepileptic drugs: is the prevention possible?","volume":"45","author":"Fukushima","year":"1991","journal-title":"Japanese Journal of Psychiatry and Neurology"},{"issue":"2-3","key":"10.1002\/14651858.CD010224.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0920-1211(98)00084-9","article-title":"Congenital malformations due to antiepileptic drugs","volume":"33","author":"Kaneko","year":"1999","journal-title":"Epilepsy Research"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1528-1157.1988.tb03746.x","article-title":"Teratogenicity of antiepileptic drugs: analysis of possible risk factors","volume":"29","author":"Kaneko","year":"1988","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0054|cit54","first-page":"306","article-title":"Teratogenicity of antiepileptic drugs and drug specific malformations","volume":"47","author":"Kaneko","year":"1993","journal-title":"Japanese Journal of Psychiatry and Neurology"},{"issue":"4 Suppl 5","key":"10.1002\/14651858.CD010224.pub3-BIB0055|cit55","first-page":"68","article-title":"Malformation in infants of mothers with epilepsy receiving antiepileptic drugs","volume":"42","author":"Kaneko","year":"1992","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4274\/tjod.galenos.2020.87300","article-title":"Obstetric outcomes in pregnant women with seizure disorder: a hospital-based, longitudinal study","volume":"17","author":"Kaur","year":"2020","journal-title":"Turkish Journal of Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajmg.1320190303","article-title":"Teratogenicity of anticonvulsant drugs II: a prospective study","volume":"19","author":"Kelly","year":"1984","journal-title":"American Journal of Medical Genetics"},{"issue":"12","key":"10.1002\/14651858.CD010224.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1111\/epi.12411","article-title":"Malformation in index pregnancy in women with epilepsy is not followed by recurrence in subsequent pregnancy","volume":"54","author":"Begum","year":"2013","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"106250","DOI":"10.1016\/j.eplepsyres.2019.106250","article-title":"Anti-epileptic drug and folic acid usage during pregnancy, seizure and malformation outcomes: changes over two decades in the Kerala Registry of Epilepsy and Pregnancy","volume":"159","author":"Keni","year":"2020","journal-title":"Epilepsy Research"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1212\/WNL.0000000000005031","article-title":"Teratogenicity of antiepileptic dual therapy: dose-dependent, drug-specific, or both?","volume":"90","author":"Keni","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/epi.16882","article-title":"Valproate usage in pregnancy: an audit from the Kerala Registry of Epilepsy and Pregnancy","volume":"62","author":"Seshachala","year":"2021","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00246-007-9161-4","article-title":"Cardiac malformations are increased in infants of mothers with epilepsy","volume":"29","author":"Thomas","year":"2008","journal-title":"Pediatric Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0063|cit63","first-page":"60","article-title":"Pregnancy in women with epilepsy: preliminary results of Kerala registry of epilepsy and pregnancy","volume":"49","author":"Thomas","year":"2001","journal-title":"Neurology India"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.seizure.2021.10.015","article-title":"Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala Registry of Epilepsy and Pregnancy (KREP)","volume":"93","author":"Thomas","year":"2021","journal-title":"Seizure"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/epi.13632","article-title":"Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: results from a pregnancy registry in South India","volume":"58","author":"Thomas","year":"2017","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(86)80949-0","article-title":"Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid","volume":"108","author":"J\u00e4ger-Roman","year":"1986","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD010224.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2008-1069536","article-title":"Anti-epileptic agents during pregnancy: a prospective study on the course of pregnancy, malformations and child development","volume":"108","author":"Koch","year":"1983","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"4 Suppl 5","key":"10.1002\/14651858.CD010224.pub3-BIB0068|cit68","first-page":"83","article-title":"Major and minor birth malformations and antiepileptic drugs","volume":"42","author":"Koch","year":"1992","journal-title":"Neurology"},{"issue":"3-4","key":"10.1002\/14651858.CD010224.pub3-BIB0069|cit69","first-page":"199","article-title":"Carbamazepine and carbamazepine-10, -11 epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects","volume":"3","author":"Kuhnz","year":"1983","journal-title":"Pediatric Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2125.1984.tb02528.x","article-title":"Ethosuximide in epileptic women during pregnancy and lactation period: placental transfer, serum concentrations in nursed infants and clinical status","volume":"18","author":"Kuhnz","year":"1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0071|cit71","first-page":"205","volume-title":"Pharmacokinetics in Teratogenesis","volume":"1","author":"Rating","year":"1987"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1651-2227.1982.tb09418.x","article-title":"Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women","volume":"71","author":"Rating","year":"1982","journal-title":"Acta Paediatrica Scandinavia"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1528-1157.1984.tb04158.x","article-title":"Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine)","volume":"25","author":"Lindhout","year":"1984","journal-title":"Epilepsia"},{"issue":"4 Suppl 5","key":"10.1002\/14651858.CD010224.pub3-BIB0074|cit74","first-page":"94","article-title":"Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations","volume":"42","author":"Lindhout","year":"1992","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nrl.2016.05.004","article-title":"Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine","volume":"33","author":"Martinez Ferri","year":"2018","journal-title":"Neurologia"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0076|cit76","first-page":"360","article-title":"Malformations and fetal death in the Spanish antiepileptic drug and pregnancy registry: results at 6 years","volume":"24","author":"Martinez Ferri","year":"2009","journal-title":"Neurologia"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2009.11.008","article-title":"Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study","volume":"19","author":"Mawer","year":"2010","journal-title":"Seizure"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000227919.81208.b2","article-title":"In utero antiepileptic drug exposure: fetal death and malformations","volume":"67","author":"Meador","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yebeh.2003.11.020","article-title":"Oxcarbazepine in pregnancy: clinical experience in Argentina","volume":"5","author":"Meischenguiser","year":"2004","journal-title":"Epilepsy & Behaviour"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00381-019-04435-2","article-title":"The impact of maternal epilepsy on delivery and neonatal outcomes","volume":"36","author":"Melikova","year":"2020","journal-title":"Child's Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0404.1992.tb04029.x","article-title":"Malformations in offspring of 305 epileptic women: a prospective study","volume":"85","author":"Battino","year":"1992","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-1211(99)00020-0","article-title":"Intrauterine growth in the offspring of epileptic women: a prospective multicentre study","volume":"36","author":"Battino","year":"1999","journal-title":"Epilepsy Research"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1528-1157.1999.tb00851.x","article-title":"Malformations in offspring of women with epilepsy: a prospective study","volume":"40","author":"Canger","year":"1999","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"535","DOI":"10.20471\/acc.2016.55.04.02","article-title":"The Croatian model of integrative prospective management of epilepsy and pregnancy","volume":"55","author":"Miskov","year":"2016","journal-title":"Acta Clinica Croatica"},{"issue":"14","key":"10.1002\/14651858.CD010224.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"e1502","DOI":"10.1212\/WNL.0000000000008687","article-title":"Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy","volume":"94","author":"Meador","year":"2020","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"100073","DOI":"10.1016\/j.ympdx.2021.100073","article-title":"Neonatal outcomes in the MONEAD study of pregnant women with epilepsy","volume":"7","author":"Van Marter","year":"2021","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.410210210","article-title":"Anticonvulsants, folate levels, and pregnancy outcome: a prospective study","volume":"21","author":"Dansky","year":"1987","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0387-7604(12)80343-3","article-title":"Improved pregnancy outcome in epileptic women in the last decade: relationship to maternal anticonvulsant therapy","volume":"14","author":"Oguni","year":"1992","journal-title":"Brain & Development"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0890-6238(92)90181-R","article-title":"Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study","volume":"6","author":"Gladstone","year":"1992","journal-title":"Reproductive Toxicology"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1096-8628(19970110)68:1<18::AID-AJMG4>3.0.CO;2-U","article-title":"Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications","volume":"68","author":"Nulman","year":"1997","journal-title":"American Journal of Medical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/tera.10044","article-title":"Effect of prenatal exposure to anticonvulsant drugs on dermal ridge patterns of fingers","volume":"66","author":"Bokhari","year":"2002","journal-title":"Teratology"},{"issue":"12","key":"10.1002\/14651858.CD010224.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/j.1528-1167.2008.01696.x","article-title":"Valproate teratogenicity and epilepsy syndrome","volume":"49","author":"Bromfield","year":"2008","journal-title":"Epilepsia"},{"issue":"21","key":"10.1002\/14651858.CD010224.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0000000000000018","article-title":"Association between topiramate and zonisamide use during pregnancy and low birth weight","volume":"123","author":"Hern\u00e1ndez-D\u00edaz","year":"2014","journal-title":"Obstetrics and Gynecology"},{"issue":"22 Pt 2","key":"10.1002\/14651858.CD010224.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","article-title":"Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy","volume":"70","author":"Holmes","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpeds.2004.08.048","article-title":"The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs","volume":"146","author":"Holmes","year":"2005","journal-title":"Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD010224.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archneurol.2011.133","article-title":"Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations","volume":"68","author":"Holmes","year":"2011","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-9926(200003)61:3<196::AID-TERA7>3.0.CO;2-T","article-title":"Intelligence and physical features of children of women with epilepsy","volume":"61","author":"Holmes","year":"2000","journal-title":"Teratology"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.0013-9580.2004.451102.x","article-title":"North American Antiepileptic Drug Pregnancy Registry","volume":"45","author":"Holmes","year":"2004","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","article-title":"Increased rate of major malformations in offspring exposed to valproate during pregnancy","volume":"64","author":"Wyszynski","year":"2005","journal-title":"Neurology"},{"issue":"13","key":"10.1002\/14651858.CD010224.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1736\u201342","DOI":"10.1111\/j.1471-0528.2009.02354.x","article-title":"Complications during pregnancy in women with epilepsy: population-based cohort study","volume":"116","author":"Borthen","year":"2009","journal-title":"British Journal of Obstetrics and Gynecology"},{"issue":"13","key":"10.1002\/14651858.CD010224.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00415-013-7239-x","article-title":"Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy","volume":"261","author":"Veiby","year":"2014","journal-title":"Journal of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1528-1167.2009.02147.x","article-title":"Pregnancy, delivery, and outcome for the child in maternal epilepsy","volume":"50","author":"Veiby","year":"2009","journal-title":"Epilepsia"},{"issue":"4 Suppl 5","key":"10.1002\/14651858.CD010224.pub3-BIB0104|cit104","first-page":"119","article-title":"The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort","volume":"42","author":"Omtzigt","year":"1992","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pd.1970121107","article-title":"Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure","volume":"12","author":"Omtzigt","year":"1992","journal-title":"Prenatal Diagnosis"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0106|cit106","first-page":"254","article-title":"Epilepsy and pregnancy: obstetrical aspects of a prospective multidisciplinary study","volume":"103","author":"Pardi","year":"1982","journal-title":"Annali di Ostetricia, Ginecologia, Medicina Perinatale"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samr\u00e9n","year":"1997","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0920-1211(94)90046-9","article-title":"Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study","volume":"18","author":"Steegers-Theunissen","year":"1994","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0404.1986.tb03271.x","article-title":"A register study of maternal epilepsy and delivery outcome with special reference to drug use","volume":"73","author":"K\u00e4ll\u00e9n","year":"1986","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1651-2227.2004.tb00701.x","article-title":"Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study","volume":"93","author":"Wide","year":"2004","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0111|cit111","first-page":"351","article-title":"The risk of malformations and developmental disturbances in children exposed to antiepileptic drugs: a prospective controlled study","volume":"95\/96","author":"Regesta","year":"1996","journal-title":"Bollettino Lega Italiana contro l'Epilessia"},{"issue":"4 Suppl 5","key":"10.1002\/14651858.CD010224.pub3-BIB0112|cit112","first-page":"89","article-title":"Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study","volume":"42","author":"Tanganelli","year":"1992","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/epi.12001","article-title":"Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero","volume":"54","author":"Campbell","year":"2013","journal-title":"Epilepsia"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers","volume":"85","author":"Campbell","year":"2014","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD010224.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.wnl.0000244491.48937.55","article-title":"Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register","volume":"67","author":"Hunt","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","article-title":"Topiramate in pregnancy","volume":"71","author":"Hunt","year":"2008","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD010224.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/jnnp-2017-317368","article-title":"Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations","volume":"89","author":"Kinney","year":"2018","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.seizure.2012.01.005","article-title":"Valproate and the risk for congenital malformations: is formulation and dosage regime important?","volume":"21","author":"Mawhinney","year":"2012","journal-title":"Seizure"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.0b013e31827f0874","article-title":"Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers","volume":"80","author":"Mawhinney","year":"2013","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.seizure.2021.07.002","article-title":"Zonisamide safety in pregnancy: data from the UK and Ireland epilepsy and pregnancy register","volume":"91","author":"McCluskey","year":"2021","journal-title":"Seizure"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/11536820-000000000-00000","article-title":"Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD","volume":"33","author":"Charlton","year":"2010","journal-title":"Drug Safety"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/11584970-000000000-00000","article-title":"Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations","volume":"34","author":"Charlton","year":"2011","journal-title":"Drug Safety"},{"issue":"7","key":"10.1002\/14651858.CD010224.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"e0131130","DOI":"10.1371\/journal.pone.0131130","article-title":"Congenital anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: a population-based cohort study","volume":"10","author":"Ban","year":"2015","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/CLEP.S118336","article-title":"Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies","volume":"9","author":"Petersen","year":"2017","journal-title":"Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","article-title":"Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study","volume":"90","author":"Hernandez-Diaz","year":"2018","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"e1003322","DOI":"10.1371\/journal.pmed.1003322","article-title":"Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US Medicaid Analytic eXtract dataset","volume":"17","author":"Patorno","year":"2020","journal-title":"PLOS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archneur.1994.00540150044014","article-title":"Outcomes of pregnancy associated with antiepileptic drugs","volume":"51","author":"Waters","year":"1994","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archneur.1974.00490420030002","article-title":"Do anticonvulsants have a teratogenic effect?","volume":"31","author":"Annegers","year":"1974","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0130|cit130","first-page":"157","article-title":"Epilepsy anticonvulsants and malformations","volume":"11","author":"Annegers","year":"1975","journal-title":"Birth Defects original article series"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0131|cit131","first-page":"579","article-title":"Congenital malformations in the offspring of epileptic mothers with and without anticonvulsant treatment","volume":"54","author":"Arteaga-Vazquez","year":"2012","journal-title":"Salud Publica Mexico"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0028-3886.24701","article-title":"Physical growth and psychomotor development of infants exposed to antiepileptic drugs in utero","volume":"54","author":"Arulmozhi","year":"2006","journal-title":"Neurology India"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0133|cit133","first-page":"203","article-title":"Epilepsy and pregnancy","volume":"33","author":"B\u00e4rmig","year":"1973","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"13","key":"10.1002\/14651858.CD010224.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-0528.2009.02354.x","article-title":"Complications during pregnancy in women with epilepsy: population-based cohort study","volume":"116","author":"Borthen","year":"2009","journal-title":"BJOG"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0135|cit135","first-page":"16","article-title":"[Fetal malformations in women with epilepsy]","volume":"48","author":"Bozhinov","year":"2009","journal-title":"Akusherstvo i Ginekologiia"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0136|cit136","first-page":"12","article-title":"The course of pregnancy and labor in patients with epilepsy","volume":"37","author":"Bozhinova","year":"1998","journal-title":"Akusherstvo i Ginekologiia"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0137|cit137","first-page":"219","article-title":"Anticonvulsants and pregnancy","volume":"43","author":"Can\u00fan-Serrano","year":"1986","journal-title":"Boleti\u0301n Me\u0301dico del Hospital Infantil de Me\u0301xico"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.eplepsyres.2014.01.021","article-title":"Topiramate monotherapy use in women with and without epilepsy: pregnancy and neonatal outcomes","volume":"108","author":"Castilla-Puentes","year":"2014","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"186\u20139","DOI":"10.1016\/S0188-0128(99)00007-X","article-title":"Facial anthropometric measurements in offspring of epileptic mothers","volume":"30","author":"D\u00edaz-Romero","year":"1999","journal-title":"Archives of Medical Research"},{"issue":"37","key":"10.1002\/14651858.CD010224.pub3-BIB0140|cit140","first-page":"2267","article-title":"Congenital developmental anomalies in the offspring of epileptic mothers","volume":"126","author":"Dobos","year":"1985","journal-title":"Orvosi Hetilap"},{"issue":"4 Suppl 5","key":"10.1002\/14651858.CD010224.pub3-BIB0141|cit141","first-page":"75","article-title":"Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study","volume":"42","author":"Dravet","year":"1992","journal-title":"Neurology"},{"issue":"33","key":"10.1002\/14651858.CD010224.pub3-BIB0142|cit142","first-page":"1371","article-title":"Congenital abnormalities, cleft lip and cleft palate in particular, in children of epileptic mothers","volume":"115","author":"Elshove","year":"1971","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0143|cit143","doi-asserted-by":"publisher","DOI":"10.3310\/hta22230","volume-title":"AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies","author":"Thangaratinam","year":"2018"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0022-3476(88)80162-8","article-title":"Minor anomalies in offspring of epileptic mothers","volume":"112","author":"Gaily","year":"1988","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.1320350425","article-title":"Distal phalangeal hypoplasia in children with prenatal phenytoin exposure: results of a controlled anthropometric study","volume":"35","author":"Gaily","year":"1990","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0920-1211(90)90041-S","article-title":"Head circumference in children of epileptic mothers: contributions of drug exposure and genetic background","volume":"5","author":"Gaily","year":"1990","journal-title":"Epilepsy Research"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0002-9378(85)90615-5","article-title":"Obstetric outcome in women with epilepsy","volume":"152","author":"Hiilesmaa","year":"1985","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6392","key":"10.1002\/14651858.CD010224.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.287.6392.577","article-title":"Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome","volume":"287","author":"Hiilesmaa","year":"1983","journal-title":"British Medical Journal"},{"issue":"17","key":"10.1002\/14651858.CD010224.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.0b013e31828f18c1","article-title":"Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study","volume":"80","author":"Fujii","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12884-018-1857-3","article-title":"Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study","volume":"18","author":"Galappatthy","year":"2018","journal-title":"BMC Pregnancy & Childbirth"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0151|cit151","first-page":"831","article-title":"Antiepileptics and congenital malformations","volume":"3","author":"Goujard","year":"1974","journal-title":"Journal de Gyne\u0301cologie, Obste\u0301trique et Biologie de la Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archpedi.1974.02110240031002","article-title":"Infants exposed in utero to antiepileptic drugs: a prospective study","volume":"127","author":"Hill","year":"1974","journal-title":"American Journal of Diseases of Children"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/tera.1420490316","article-title":"Anticonvulsant teratogenesis: 1. A study design for newborn infants","volume":"49","author":"Holmes","year":"1994","journal-title":"Teratology"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"e58213","DOI":"10.1371\/journal.pone.0058213","article-title":"Developmental enamel defects in children prenatally exposed to anti-epileptic drugs","volume":"8","author":"Jacobsen","year":"2013","journal-title":"PLOS One"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"e84420","DOI":"10.1371\/journal.pone.0084420","article-title":"Prenatal exposure to antiepileptic drugs and dental agenesis","volume":"9","author":"Jacobsen","year":"2014","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.seizure.2022.01.013","article-title":"Clinical predictors for breastfeeding initiation among women with epilepsy","volume":"96","author":"Jedrzejczak","year":"2022","journal-title":"Seizure"},{"issue":"25","key":"10.1002\/14651858.CD010224.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM198906223202505","article-title":"Pattern of malformations in the children of women treated with carbamazepine during pregnancy","volume":"320","author":"Jones","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1528-1157.1975.tb04726.x","article-title":"Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients","volume":"16","author":"Knight","year":"1975","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1528-1167.2007.01021.x","article-title":"Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study","volume":"48","author":"Cunnington","year":"2007","journal-title":"Epilepsia"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.0013-9580.2004.451105.x","article-title":"The International Lamotrigine Pregnancy Registry update for the Epilepsy Foundation","volume":"45","author":"Cunnington","year":"2004","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0161|cit161","unstructured":"Final report: 1 September 1992\u201331 March 2010 pregnancyregistry.gsk.com\/documents\/lam_spring_2010_final_report.pdf"},{"issue":"10","key":"10.1002\/14651858.CD010224.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1528-1157.2002.45901.x","article-title":"Preliminary results on pregnancy outcomes in women using lamotrigine","volume":"43","author":"Tennis","year":"2002","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0163|cit163","first-page":"35","article-title":"Evaluation of antiepileptic therapy during pregnancy","volume":"73","author":"Laskowska","year":"2002","journal-title":"Ginekologia Polska"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0164|cit164","first-page":"271","article-title":"Prospective surveillance of Croatian pregnant women on lamotrigine monotherapy - aspects of pre-pregnancy counseling and drug monitoring","volume":"48","author":"Miskov","year":"2009","journal-title":"Acta Clinica Croatica"},{"issue":"20","key":"10.1002\/14651858.CD010224.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJM197311152892001","article-title":"Diphenylhydantoin and selected congenital malformations","volume":"289","author":"Monson","year":"1973","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1525-5050(03)00110-0","article-title":"Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry","volume":"4","author":"Montouris","year":"2003","journal-title":"Epilepsy & Behavior"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp-2017-317833","article-title":"Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health","volume":"89","author":"Mostacci","year":"2018","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010224.pub3-BIB0168|cit168","first-page":"131","article-title":"Prevalence of antiepileptic drugs exposure in pregnant women in the Emilia Romagna region (Italy): results from the ESPEA (Emilia Romagna Study on Pregnancy and Exposure to Antiepileptic Drugs)","volume":"55","author":"Mostacci","year":"2014","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0169|cit169","first-page":"592","article-title":"Reexamination of the teratological effect of antiepileptic drugs","volume":"42","author":"Murasaki","year":"1988","journal-title":"Japanese Journal of Psychiatry and Neurology"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1528-1157.1980.tb04320.x","article-title":"Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan","volume":"21","author":"Nakane","year":"1980","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0171|cit171","first-page":"363","article-title":"Congenital malformation among infants of epileptic mothers treated during pregnancy: the report of a collaborative study group in Japan","volume":"33","author":"Nakane","year":"1979","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/pds.2630010603","article-title":"A pregnancy register of patients receiving carbamazepine in the UK","volume":"1","author":"Pearse","year":"1992","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajog.2003.09.020","article-title":"Epilepsy and pregnancy: an obstetric perspective","volume":"190","author":"Richmond","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6-7","key":"10.1002\/14651858.CD010224.pub3-BIB0174|cit174","first-page":"445","article-title":"Is valproic acid teratogenic?","volume":"139","author":"Robert","year":"1983","journal-title":"Revue Neurologique"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1034\/j.1600-0404.2003.00200.x","article-title":"Epilepsy and pregnancy: lamotrigine as main drug used","volume":"109","author":"Sabers","year":"2004","journal-title":"Acta Neurologica Scandinavica"},{"issue":"13","key":"10.1002\/14651858.CD010224.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/bdr2.1526","article-title":"Levetiracetam Pregnancy Registry: final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations","volume":"111","author":"Scheuerle","year":"2019","journal-title":"Birth Defects Research"},{"issue":"7954","key":"10.1002\/14651858.CD010224.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(76)91403-3","article-title":"Anticonvulsants and parental epilepsy in the development of birth defects","volume":"1","author":"Shapiro","year":"1976","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0303-8467(74)80001-6","article-title":"Teratogenicity of antiepileptic drugs","volume":"77","author":"Starveld-Zimmerman","year":"1975","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/bdra.23357","article-title":"Topiramate use during pregnancy and major congenital malformations in multiple populations","volume":"103","author":"Tennis","year":"2015","journal-title":"Birth Defects Research"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0180|cit180","first-page":"282","article-title":"Epilepsy and pregnancy: risks and benefits of anticonvulsant treatments","volume":"63","author":"Torres","year":"1995","journal-title":"Ginecologia y Obstetricia de Mexico"},{"issue":"2","key":"10.1002\/14651858.CD010224.pub3-BIB0181|cit181","first-page":"87","article-title":"Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study","volume":"42","author":"Wide","year":"2000","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"12","key":"10.1002\/14651858.CD010224.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"e0189497","DOI":"10.1371\/journal.pone.0189497","article-title":"Antiepileptic drug use among women from the Taiwanese Registry of Epilepsy and Pregnancy: obstetric complications and fetal malformation outcomes","volume":"12","author":"Yeh","year":"2017","journal-title":"PLOS One"},{"issue":"4 Suppl 5","key":"10.1002\/14651858.CD010224.pub3-BIB0183|cit183","first-page":"132","article-title":"Antiepileptics and the development of congenital anomalies","volume":"42","author":"Yerby","year":"1992","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010224.pub3-BIB0184|cit184","first-page":"128, Abstract n","article-title":"Postnatal concerns in children born to women with juvenile myoclonic epilepsy","volume":"55","author":"Babic","year":"2014","journal-title":"Epilepsia"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0185|cit185","first-page":"844, Abstract n","article-title":"Pregnancy outcomes in women using antiepileptic drugs","volume":"36","author":"Kaabi","year":"2013","journal-title":"Drug Safety"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010224.pub3-BIB0186|cit186","first-page":"127","article-title":"Follow up and treatment of women with epilepsy during pregnancy","volume":"54","author":"Kutlu","year":"2013","journal-title":"Epilepsia"},{"issue":"3-4","key":"10.1002\/14651858.CD010224.pub3-BIB0187|cit187","first-page":"75","article-title":"Intrauterine exposure to drugs: analysis of a sample of newborn infants pretreated with anticonvulsants","volume":"38","author":"Lazzaroni Fossati","year":"1986","journal-title":"Minerva Pediatrica"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010224.pub3-BIB0188|cit188","first-page":"132, Abstract n","article-title":"Antiepileptic drug usage and the effects of them on the foetus in epileptic pregnant woman","volume":"55","author":"Midi","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010224.pub3-BIB0189|cit189","first-page":"131, Abstract n","article-title":"Pregnant women with epilepsy: 43 patients results in 1 year period","volume":"54","author":"Midi","year":"2013","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD010224.pub3-BIB0190|cit190","first-page":"377","article-title":"[Congenital malformations and anticonvulsant therapy in pregnancy]","volume":"110","author":"Shvartzman","year":"1986","journal-title":"Harefuah"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010224.pub3-BIB0191|cit191","first-page":"130, Abstract n","article-title":"Antiepileptic drug therapy during pregnancy and obstetric outcomes in Moscow region: comparing of 1998 and 2013 years","volume":"55","author":"Vlasov","year":"2014","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"443\u20137","DOI":"10.1136\/adc.2008.144386","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers","year":"2009","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.reprotox.2015.03.003","article-title":"First trimester exposure to topiramate and the risk of oral clefts in the offspring: a systematic review and meta-analysis","volume":"53","author":"Alsaad","year":"2015","journal-title":"Reproductive Toxicology"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajmg.1320290123","article-title":"Verification of the fetal valproate syndrome phenotype","volume":"29","author":"Ardinger","year":"1988","journal-title":"American Journal of Medical Genetics"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD010224.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1542\/peds.113.S3.957","article-title":"Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors","volume":"113","author":"Brent","year":"2004","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD010224.pub3-BIB0196|cit196","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010236.pub2","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","author":"Bromley","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00002018-200831010-00004","article-title":"Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries","volume":"31","author":"Charlton","year":"2008","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.reprotox.2014.02.004","article-title":"The fetal safety of levetiracetam: a systematic review","volume":"46","author":"Chaudhry","year":"2014","journal-title":"Reproductive Toxicology"},{"issue":"16","key":"10.1002\/14651858.CD010224.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"e186606","DOI":"10.1001\/jamanetworkopen.2018.6606","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit\/hyperactivity disorder in offspring","volume":"2","author":"Christensen","year":"2019","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13023-019-1064-y","article-title":"Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability","volume":"14","author":"Clayton-Smith","year":"2019","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"233\u20134","DOI":"10.1053\/seiz.2000.0392","article-title":"Developing diagnostic criteria for the fetal anticonvulsant syndromes","volume":"9","author":"Dean","year":"2000","journal-title":"Seizure"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","article-title":"The fetal valproate syndrome","volume":"19","author":"DiLiberti","year":"1984","journal-title":"American Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0204|cit204","unstructured":"EUROCAT European Surveillance of Congenital Anomalies EUROCAT guide 1.3 and reference documents: instructions for the registration and surveillance of congenital anomalies eu-rd-platform.jrc.ec.europa.eu\/sites\/default\/files\/EUROCAT-Guide-1.3.pdf"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"issue":"7650","key":"10.1002\/14651858.CD010224.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0207|cit207","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"23","key":"10.1002\/14651858.CD010224.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"c6581","DOI":"10.1136\/bmj.c6581","article-title":"Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study","volume":"341","author":"Jentink","year":"2010","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jmedgenet-2011-100242","article-title":"Studying the epigenome using next generation sequencing","volume":"48","author":"Ku","year":"2011","journal-title":"Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"e52339","DOI":"10.1371\/journal.pone.0052339","article-title":"Antiepileptic drugs during pregnancy in primary care: a UK population based study","volume":"7","author":"Man","year":"2012","journal-title":"PLOS One"},{"issue":"5","key":"10.1002\/14651858.CD010224.pub3-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"405.e1","DOI":"10.1016\/j.ajog.2012.07.008","article-title":"Use of topiramate in pregnancy and risk of oral clefts","volume":"207","author":"Margulis","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"9566","key":"10.1002\/14651858.CD010224.pub3-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","article-title":"Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts","volume":"81","author":"Meador","year":"2008","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yebeh.2009.04.026","article-title":"Antiepileptic drug use in women of childbearing age","volume":"15","author":"Meador","year":"2009","journal-title":"Epilepsy and Behaviour"},{"issue":"10","key":"10.1002\/14651858.CD010224.pub3-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"1017\u201325","DOI":"10.1002\/pds.3612","article-title":"Topiramate use in pregnancy and the birth prevalence of oral clefts","volume":"23","author":"Mines","year":"2014","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0217|cit217","unstructured":"National Institute for Clinical Excellence (NICE) Epilepsies in children, young people and adults. NICE guideline [NG217] www.nice.org.uk\/guidance\/ng217"},{"issue":"4","key":"10.1002\/14651858.CD010224.pub3-BIB0218|cit218","first-page":"192","article-title":"Zonisamide: a new antiepileptic drug","volume":"22","author":"Oommen","year":"1999","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD010224.pub3-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD010224.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/epi.16905","article-title":"Antiseizure medications and fetal nutrients: effects on choline transporters in a human placental cell line","volume":"62","author":"Tetro","year":"2021","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD010224.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1002\/14651858.CD010224.pub3-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD010224.pub3-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"Veroniki","year":"2017","journal-title":"BMC Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010224.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/WNL.0000000000001304","article-title":"Antiepileptic drug use by pregnant women enrolled in Florida Medicaid","volume":"84","author":"Wen","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD010224.pub3-BIB0225|cit225","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004848","article-title":"Common antiepileptic drugs in pregnancy in women with epilepsy","author":"Adab","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0226|cit226","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010224","article-title":"Treatment for epilepsy in pregnancy: congenital malformation outcomes in the child","author":"Pulman","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD010224.pub3-BIB0227|cit227","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010224.pub2","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","author":"Weston","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:10:10Z","timestamp":1750032610000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010224.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":227,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010224.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]}}}